Life sciences news
-
New US studies demonstrate Idylla™ allows rapid first assessment of most common EGFR mutations preceding next-generation sequencing
Wednesday February 3rd 2021
Read more
-
argenx announces “GO” Decision in ADHERE trial of Efgartigimod in Chronic Inflammatory Demyelinating Polyneuropathy following interim analysis
Tuesday February 2nd 2021
Read more
-
Euronext Biotech Barometer H2 2020
Monday February 1st 2021
Read more
-
Novalis Biotech announces acquisition of Doc.ai by Sharecare
Monday February 1st 2021
Read more
-
Belgian initiative for AI lung scan analysis in fight against COVID-19 goes European
Wednesday January 27th 2021
Read more
-
Nomination of Christophe Maréchal as interim CEO
Friday January 22nd 2021
Read more
-
Biotalys submits first protein-based biocontrol registration package to the EPA
Friday January 22nd 2021
Read more
-
Targeting Tau to keep neurons connected
Thursday January 21st 2021
Read more
-
Become a flanders.bio member
Your news here?
-
reMYND extends Series B funding to EUR 24 million
Thursday January 21st 2021
Read more
-
NICE recommends Jyseleca® (filgotinib) on NHS in landmark decision for rheumatoid arthritis
Thursday January 21st 2021
Read more
-
Blue Matter announces acquisition of AIM, a leading European supply chain consulting firm
Wednesday January 20th 2021
Read more
More info?
Contact us
Ellen Telleir
Communication Coordinator
